# Beta Bionics, Inc.: filings

BBNX · Nasdaq · CIK 1674632 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbnx.md) · [Financials](/companies/bbnx/financials.md) · [Filings](/companies/bbnx/filings.md) · [Insiders](/companies/bbnx/insiders.md)

## Reports and events: 31 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 99, 144 46, 8-K 17, SCHEDULE 13G/A 17, SCHEDULE 13G 13, 3 12, C-AR 8, 4/A 7, 10-Q 6, CORRESP 5, UPLOAD 5, D 4, C-AR/A 3, DRS/A 3, DRSLTR 3, S-1/A 3, SEC STAFF LETTER 3, 10-K 2, 424B5 2, C/A 2, D/A 2, S-8 2, 10-K/A 1, 144/A 1, 424B4 1, 8-A12B 1, ARS 1, C 1, CERT 1, C-U 1, DEF 14A 1, DEFA14A 1, DRS 1, EFFECT 1, FWP 1, S-1 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-27 | 16:20 ET | [10-Q](/filings/0001674632-26-000003.md) | Quarterly report, period 2026-09-30 | 0001674632-26-000003 |
| 2026-10-27 | 16:04 ET | [8-K](/filings/0001171843-26-006856.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006856 |
| 2026-09-17 | 18:24 ET | [8-K](/filings/0001193125-26-393322.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-393322 |
| 2026-09-15 | 16:58 ET | [8-K](/filings/0001193125-26-392088.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-392088 |
| 2026-07-29 | 16:20 ET | [10-Q](/filings/0001193125-26-323777.md) | Quarterly report, period 2026-06-30 | 0001193125-26-323777 |
| 2026-07-29 | 16:04 ET | [8-K](/filings/0001171843-26-005010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005010 |
| 2026-05-22 | 16:05 ET | [8-K](/filings/0001171843-26-003648.md) | 5.07 Shareholder vote results | 0001171843-26-003648 |
| 2026-05-21 | 16:06 ET | [8-K](/filings/0001171843-26-003617.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-003617 |
| 2026-04-21 | 16:20 ET | [10-Q](/filings/0001193125-26-166843.md) | Quarterly report, period 2026-03-31 | 0001193125-26-166843 |
| 2026-04-21 | 16:05 ET | [8-K](/filings/0001171843-26-002614.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002614 |
| 2026-04-10 | 16:05 ET | [DEF 14A](/filings/0001193125-26-151235.md) | Proxy statement, period 2026-05-21 | 0001193125-26-151235 |
| 2026-02-24 | 16:20 ET | [10-K](/filings/0001193125-26-067065.md) | Annual report, period 2025-12-31 | 0001193125-26-067065 |
| 2026-02-17 | 16:06 ET | [8-K](/filings/0001171843-26-000859.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000859 |
| 2026-01-30 | 16:30 ET | [8-K](/filings/0001171843-26-000538.md) | 8.01 Other events | 0001171843-26-000538 |
| 2026-01-08 | 16:08 ET | [8-K](/filings/0001171843-26-000145.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000145 |
| 2025-10-28 | 16:20 ET | [10-Q](/filings/0001193125-25-253538.md) | Quarterly report, period 2025-09-30 | 0001193125-25-253538 |
| 2025-10-28 | 16:04 ET | [8-K](/filings/0001171843-25-006720.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006720 |
| 2025-07-29 | 16:20 ET | [10-Q](/filings/0000950170-25-099652.md) | Quarterly report, period 2025-06-30 | 0000950170-25-099652 |
| 2025-07-29 | 16:04 ET | [8-K](/filings/0001171843-25-004780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004780 |
| 2025-06-23 | 07:31 ET | [8-K](/filings/0001171843-25-004016.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004016 |
| 2025-05-06 | 16:20 ET | [10-Q](/filings/0000950170-25-064504.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064504 |
| 2025-05-06 | 16:03 ET | [8-K](/filings/0001171843-25-002817.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002817 |
| 2025-03-28 | 16:05 ET | [10-K/A](/filings/0000950170-25-046762.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-046762 |
| 2025-03-27 | 16:45 ET | [8-K](/filings/0001171843-25-001785.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-001785 |
| 2025-03-25 | 17:00 ET | [10-K](/filings/0000950170-25-044516.md) | Annual report, period 2024-12-31 | 0000950170-25-044516 |
| 2025-03-25 | 16:03 ET | [8-K](/filings/0001171843-25-001690.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001690 |
| 2025-01-31 | 17:10 ET | [8-K](/filings/0001193125-25-018471.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-018471 |
| 2025-01-28 | 09:11 ET | [S-1/A](/filings/0001193125-25-013987.md) | Registration statement, amended | 0001193125-25-013987 |
| 2025-01-23 | 17:06 ET | [S-1/A](/filings/0001193125-25-011507.md) | Registration statement, amended | 0001193125-25-011507 |
| 2025-01-22 | 06:10 ET | [S-1/A](/filings/0001193125-25-009915.md) | Registration statement, amended | 0001193125-25-009915 |
| 2025-01-06 | 16:25 ET | [S-1](/filings/0001193125-25-002177.md) | Registration statement | 0001193125-25-002177 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:23 ET. No prices; not investment advice.